OASIS |
Outcome and Assessment Information Set. The set of data that HCFA requires HHAs to collect on their patients. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OBC |
See Orange Book Code. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Off-label Use |
When the US FDA approves a drug, it approves it for specific, explicit treatments. Any other use of the drug is considered off-label (i.e., unapproved). For example, a cancer drug approved for adults could help children. In that case, prescribing the drug for children would be considered off-label. Physicians can still prescribe drugs off-label because this kind of use falls within a physicians traditional discretion regarding the practice of medicine. Although a drug may not been approved for a specific treatment, off-label use is not likely to result in enforcement action by the FDS. However, anyone advertising or promoting the off-label use would be subject to enforcement by the FDA. In particular, drug companies are forbidden from providing doctors and patients with verbal or written information about medical research demonstrating how a drug approved for one medical problem might help solve another. Physicians may test off-label use of a drug and even publish their findings in the medical literature, but drug companies cannot hand out reprints of such articles. An April, 1996 article in Ocular Surgery News journal claims that off-label use is mostly beneficial and to support it lists the following statistics,
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OIG |
The Office of the Inspector General of the department of Health and Human Service is responsible for investigating healthcare fraud. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Official Inventory |
Inventory maintained on the general ledger (GL) as an asset to the organization. See Unofficial Inventory, also Non-Stock Item and Non-System Item. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OMG |
The Object Management Group (OMG) is a non-profit consortium dedicated to promoting the theory and practice of object technology (OT) for the development of distributed computing systems. OMG was formed to help reduce the complexity, lower the costs, and hasten the introduction of new software applications. Its goal is to provide a common architectural framework (i.e., CORBA) for object-oriented applications based on widely available interface specifications. Its international membership currently stands at over 600 software vendors, software developers and end users. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OmniLinkSM |
McKessonHBOCs OmniLink centralized pharmacy software, offers pharmacies a way to help streamline transactions and claims processing; it is designed to increase a pharmacys efficiency and profitability, including daily updates on average wholesale pricing. Heres how it works:
Keeping up with competition and administrative
details are daunting challenges in todays increasingly complex
managed care environment, especially for pharmacies that must meet
compliance requirements and deliver quality patient care. In the past
four years 12% of independent pharmacies have sold out to competitors
or closed their doors. Managed care organizations are definitely driving
the marketplace today. OmniLink and the CareMaxSM
network help independents to compete in this managed care environment.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
On Order |
The stock on order is the quantity represented by the total of all outstanding supply requisitions. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
One-CallTM |
The industrys leading commercial enterprise-wide patient scheduling system. This is a product of the company formerly known as Atwork, now a part of Medaphis. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
One-StaffTM |
The industrys leading commercial enterprise-wide personnel scheduling system. This is a product of the company formerly known as Atwork, now a part of Medaphis. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Open Access |
A feature of progressive insurance plans that allow its members to go directly to specialists (i.e., without having to first get a referral from a gatekeeper Physician). |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Open Requisition |
A supply requisition that has been printed, sent to the vendor, but not replenished completely. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Open-Ended HMO |
HMOs that allow members to use out-of-network providers and still receive partial coverage. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Operate |
The degree of control a corporation or individual has over the operations of a consumer health web site. A corporation or individual operates a consumer health web site if the corporation or individual is primarily responsible for the material that appears on the site, including, but not limited to, advertising, health information content, services and products. [Source: Hi-Ethics Coalition] |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OPPS |
Medicares Outpatient Prospective Payment System. A HCFA payment system for outpatients. This proposal has come and gone in the politics of Washington, but it is finally scheduled to be launched nationally on July 1, 2000. For more information, check out the PPS Resource Center. Click on Newsletters and then PPS Alert. See APC. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Opt-In |
An affirmative ability for a consumer to accept terms and conditions. [Source: Hi-Ethics Coalition] |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OR |
Operating Room. Also known as Operating Theater, outside the US. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Orange Book Code |
The Orange Book Code (OBC) identifies the therapeutic equivalency ratings assigned to each approved prescription product according to the FDAs Approved Drug Products with Therapeutic Equivalence Evaluations (i.e., the Orange Book). A code is assigned to all products on FDBs NDDF regardless of whether it has been evaluated in the prescription section of the Orange Book. The OBC is specific to a particular pharmaceutical item and the five-digit labeler code. Each drug record has only one equivalency rating. When there is more than one equivalency rating for a particular manufacturers product, the higher rating is assigned. The Orange Book, although the single most complete source of equivalency information at this time, has some limitations.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Order Count |
The quantity represented by the total of all outstanding supply requisitions. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Order Quantity |
The amount of a particular item that is ordered from a vendor each time the available stock (on hand plus on order) falls below the reorder point. Also called lot size. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ordering Cost |
The costs for placing orders, expediting, inspection, and changing or setting up facilities to produce in-house. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORSOSTM |
The industrys leading commercial OR scheduling system. This is a product of the company formerly known as Atwork, now a part of Medaphis. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORT |
Operation Restore Trust. In 1993 the Clinton Administration launched a campaign designed to reduce fraud, abuse and waste within the Medicare and Medicaid programs. DHHS initiated Operation Restore Trust in May 1995. ORT effectively coordinated the efforts of HCFA, HHS Inspector General, and the HHS Administration on Aging to investigate healthcare fraud. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OTC |
Over the counter. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Outcomes |
The results of specific treatment plans. Possible outcomes may be,
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Out of Plan |
Providers who are not contracted with a managed care network. HMOs will not reimburse visits to an out of plan provider, but PPOs do. See also out of network. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Out of Network |
Same as out of plan. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Outpatient |
A patient registered for outpatient treatment (e.g., emergency care, outpatient surgery, outpatient clinic). The patient receives healthcare services treatment without an overnight stay in a hospital or inpatient facility. With the advent of managed care in the US, many risk carriers (e.g., insurance companies, large employers) limit the type and number of tests and procedures (including surgery) that are covered only if they are performed on an outpatient basis. See also ambulatory. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Outpatient Process |
Description of outpatient process,
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OWA |
Other Weird Arrangements. In the book The New Rules of Healthcare Marketing: 23 strategies for success, the author, Arthur C Sturm, Jr. says, Hospitals, physician practices, and other entities are teaming up to work with a daunting alphabet soup of arrangements, from IDNs to GPWWs to OWAs. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OWCP |
Office of Workers Compensation Programs. Among other things, they administer the FECA. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|